Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-014846

Options or other derivatives

  • Exec. VP, European Commercial acquired 82,393 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Daniell Richard · Exec. VP, European Commercial

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-28 Grant or award : show line 1 in the form Restricted Share Units +82,393 82,393 D
Loading xslF345X03/doc4.xml…